Former CDC Head Hired To Boost Merck $5B Vaccine Division
Dr. Julie Gerberding LEARN MORE Merck & Co. Web site Merck News Room announcing appointment Merck responds to Archives of Internal Medicine article on Vioxx – November 2009 IMAGE SOURCE: Dr. Julie Gerberding / on Web site Adventures in Autism Former Centers for Disease Control and Prevention (CDC) director, Dr. Julie Gerberding, has been named the head of Merck & Co.’s $ 5 billion vaccine
Link to original article
HeartCenterOnline For Patients - Scientists give more evidence of Vioxx heart risks (Heart Center Online)
Jan 26 (Reuters) - Vioxx, the painkiller recalled last September because of safety concerns, may have caused up to 140,000 cases of serious heart disease in the United States, researchers said on Tuesday.
Click here for more info.
Merck releases study information on Arcoxia
Merck & Co. Inc. Wednesday announced preliminary information from a study of a drug that is considered Merck's follow-up to the discontinued Vioxx arthritis and pain medication.
Link to original article
Life After Vioxx: 10 Alternatives to Prescription Drugs - ThirdAge
As if the pain of sore and swollen joints isn't bad enough, now arthritis sufferers have to endure the confusion and frustration of having some of their most effective pain relievers declared risky.
Click here for more info